| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
General Counsel
1 company
Moore John R is a General Counsel at Edgewise Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 17 sells.
Estimated insider holdings value: $435K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 6, 2022 | EWTX Edgewise Therapeutics, Inc. | General Counsel | Sale+OE | 9,232 | $8.37 | $77,256.36 | -60.6% | +23.7% | -9.1% | |
| Jun 21, 2022 | EWTX Edgewise Therapeutics, Inc. | General Counsel | Sale+OE | 67,927 | $6.83 | $463,934.93 | -88.3% | +20.5% | +7.7% | |
| Jun 15, 2022 | EWTX Edgewise Therapeutics, Inc. | General Counsel | Sale+OE | 26,381 | $6.08 | $160,456.51 | -46.7% | +67.0% | +41.1% | |
| Jun 10, 2022 | EWTX Edgewise Therapeutics, Inc. | General Counsel | Sale+OE | 27,306 | $6.44 | $175,878.36 | -75.2% | +102.3% | +61.6% | |
| Jun 7, 2022 | EWTX Edgewise Therapeutics, Inc. | General Counsel | Sale+OE | 47,287 | $6.26 | $295,984.99 | -79.8% | +56.8% | +47.8% | |
| May 16, 2022 | EWTX Edgewise Therapeutics, Inc. | General Counsel | Sell | 10,800 | $7.42 | $80,145.72 | -78.3% | +47.6% | +28.4% |